The evaluation and prediction of the ecologic impact of antibiotics in human phase I and II trials.
Edlund
C
C
Department of Microbiology, Pathology and Immunology, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden. carl.erik.nord@impi.ki.se
Nord
C E
CE
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017753:Ecosystem; D005069:Evaluation Studies as Topic; D005544:Forecasting; D006801:Humans; D008826:Microbial Sensitivity Tests; D011237:Predictive Value of Tests; D012107:Research Design; D013223:Statistics as Topic
D000900:Anti-Bacterial Agents